Showing results (941-950 of 2,407) with videos related to

Sort By:
Pageof 241
Future Medicinal Chemistry|October 2, 2018
Synthesis and in vitro antioxidant activity of new pyrimidin/benzothiazol-substituted piperazinyl flavonesAleksandra Kładna, Paweł Berczyński, Oya Bozdağ Dündar, et al.
Future Medicinal Chemistry|October 6, 2018
Deep learning and virtual drug screeningKristy A Carpenter, David S Cohen, Juliet T Jarrell, et al.
Future Medicinal Chemistry|June 5, 2019
Novel 2,6-diketopiperazine-derived acetohydroxamic acids as promising anti-Trypanosoma brucei agentsGeorge Fytas, Grigoris Zoidis, Martin C Taylor, et al.
Future Medicinal Chemistry|June 5, 2019
Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platformJuan Antonio Garcia-Leon, Javier Vitorica, Antonia Gutierrez
Future Medicinal Chemistry|October 12, 2018
Targeting the mitochondrial apoptosis pathway by a newly synthesized COX-2 inhibitor in pediatric ALL lymphocytesMarjan Aghvami, Ahmad Salimi, Peyman Eshghi, et al.
Future Medicinal Chemistry|April 18, 2019
Design and implementation of novel nutraceuticals and derivatives for treating intestinal disordersMaria J Barahona, Vanessa Baratta, Jenna Ollodart, et al.
Future Medicinal Chemistry|April 19, 2019
Small-molecule inhibitors of lysine methyltransferases SMYD2 and SMYD3: current trendsEdoardo Fabini, Elisabetta Manoni, Claudia Ferroni, et al.
Future Medicinal Chemistry|April 19, 2019
Voltage-dependent anion channel isoform 3 as a potential male contraceptive drug targetAndonis Karachitos, Hanna Kmita
Future Medicinal Chemistry|July 9, 2019
Novel [1,2,3]triazolo[1,5-a]pyridine derivatives are trypanocidal by sterol biosynthesis pathway alterationMichel Lapier, Rafael Ballesteros-Garrido, Daniela Guzman-Rivera, et al.
Future Medicinal Chemistry|July 9, 2019
Hit identification of SMYD3 enzyme inhibitors using structure-based pharmacophore modelingSoraya M Alnabulsi, Nizar A Al-Shar'i
Pageof 241